Log In
Print this Print this

soluferon (VPM5001)

  Manage Alerts
Collapse Summary General Information
Company Vakzine Projekt Management GmbH
DescriptionSecond generation modified type-1 interferon (IFN) beta
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today